SESN stock forecast
Our latest prediction for Sesen Bio, Inc.'s stock price was made on the Feb. 14, 2017 when the stock price was at 2.08$.
In the short term (2weeks), SESN's stock price should outperform the market by 1.67%. During that period the price should oscillate between -8.37% and +13.04%.
In the medium term (3months), SESN's stock price should outperform the market by 6.11%. During that period the price should oscillate between -17.62% and +32.54%.Get email alerts
About Sesen Bio, Inc.
Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.68$ per share.
The book value per share is 0.83$
Three months stock forecastFeb. 14, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|